Oxysterols and neurodegenerative diseases |
| |
Authors: | Ingemar Björkhem Angel Cedazo-Minguez Valerio Leoni Steve Meaney |
| |
Affiliation: | 1. Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, 141 86 Huddinge, Sweden;2. Neurotec Department, Karolinska Institutet, Karolinska University Hospital, 141 86 Huddinge, Sweden;3. Division of Biochemistry and Genetics, “C.Besta” Neurological Institute, Milan, Italy;4. School of Biological Sciences, Faculty of Science, Dublin Institute of Technology, Dublin, Ireland |
| |
Abstract: | In contrast to their parent molecule cholesterol, two of its side-chain oxidized metabolites are able to cross the blood–brain barrier. There is a concentration-driven flux of 24S-hydroxycholesterol (24S-OHC) from the brain into the circulation, which is of major importance for elimination of excess cholesterol from the brain. The opposite flux of 27-hydroxycholesterol (27-OHC) from the circulation into the brain may regulate a number of key enzymes within the brain. In vitro experiments suggest that the balance between the levels of these two molecules may be of importance for the generation of β-amyloid peptides. In primary cultures of rat hippocampal cells 27-OHC is able to suppress expression of the activity regulated cytoskeleton-associated protein (Arc), a protein important in memory consolidation which is reduced in patients with Alzheimer’s disease (AD). In the present work we explore the possibility that the flux of 27-OHC from the circulation into the brain represents the missing link between AD and hypercholesterolemia, and discuss the possibility that modification of this flux may be a therapeutic strategy. Lastly, we discuss the use of oxysterols as diagnostic markers in neurodegenerative disease. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|